Benefit-risk balance for marketed drugs: evaluating safety signals

Benefit-risk balance for marketed drugs: evaluating safety signals

Sábháilte in:

Sonraí bibleagrafaíochta
Údar corparáideach:	Council for International Organizations of Medical Sciences (CIOMS)
Formáid:	LEABHAR
Teanga:	English
Foilsithe / Cruthaithe:	Geneva Council for International Organizations of Medical Sciences (CIOMS) 1998
Ábhair:	Drugs Pharmaceutic Preparations Pharmaceutical Products Preparations, Pharmaceutical
Rochtain ar líne:	Visit NHRC Library
Clibeanna:	Cuir clib leis Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!

Míreanna comhchosúla

Martindale: the complete drug reference
de réir: Parfitt, Kathleen
Foilsithe / Cruthaithe: (1999)

WHO drug information.
Foilsithe / Cruthaithe: (2000)

WHO expert committee on specifications for pharmaceutical preparations
Foilsithe / Cruthaithe: (2006)

International nonproprietary names (INN) for pharmaceutical substances : lists 1-65 of proposed INN and lists 1-31 of recommended INN : cumulative list no. 8 = Dénominations communes internationales (DCI) pour les substances pharmaceutiques : listes 1-65 de DCI proposées et listes 1-31 de DCI recommandées : liste récapitulative no. 8.
Foilsithe / Cruthaithe: (1992)

WHO expert committee on specifications for pharmaceutical preparations
Foilsithe / Cruthaithe: (2011)

WHO Expert Committee on Specifications for Pharmaceutical Preparations
Foilsithe / Cruthaithe: (2012)

USP DI. Approved drug products and legal requirements.
Foilsithe / Cruthaithe: (1995)

Where there are no pharmacists : a guide to managing medicines for all health workers /
de réir: Andersson, Sarah
Foilsithe / Cruthaithe: (2010)

Managing drug supply : the selection, procurement, distribution, and use of pharmaceuticals. the selection, procurement, distribution, and use of pharmaceuticals.
Foilsithe / Cruthaithe: (1997)

Pharmacology : a patient-centered nursing process approach /
de réir: Kee, Joyce LeFever, et al.

Drug calculations : ratio and proportion problems for clinical practice /
de réir: Seltzer, Meta Brown, et al.

Effective drug regulation a multicountry study /
de réir: Ratanawijitrasin, Sauwakon
Foilsithe / Cruthaithe: (2002)

WHO Expert Committee on Specifications for Pharmaceutical Preparations : forty-eighth meeting report /

Preparation of hazardous waste inventory
de réir: DEVS Consult Nepal (P) Ltd.
Foilsithe / Cruthaithe: (2013)

Client satisfaction and quality of curative services for sick children in Nepal: further analysis of the 2015 Nepal Health Facility Survey: DHS further analysis reports No. 114.
de réir: Acharya,Kiran
Foilsithe / Cruthaithe: (2018)

Regulatory Situation of Herbal Medicines
Foilsithe / Cruthaithe: (1998)

A text book of pharmacognosy.
de réir: Raut, Bechan, et al.
Foilsithe / Cruthaithe: (2007)

Status of Ayurvedic Medicines Available in the Markets of Nepal
de réir: Adhikari, SM, et al.
Foilsithe / Cruthaithe: (2016)

The Selection and Use of Essential Medicines Reports of the WHO Expert Committee on the Selection and Use of Essential Medicines and the 3rd WHO Model list of essential medicines for children
Foilsithe / Cruthaithe: (2012)

AHFS drug information 2000
de réir: Snow, Elaine, K
Foilsithe / Cruthaithe: (2000)

Safety requirements for the first use of new drugs and diagnostic agents in man : a review of safety issues in early clinical trials of drugs.
Foilsithe / Cruthaithe: (1983)

Final Report on Development of Profile of Toxic Waste Products in Nepal
de réir: Nepal Health Research Council (NHRC), et al.
Foilsithe / Cruthaithe: (2013)

Serotyping and antibiotic resistance profile of common bacterial isolates causing gastroenteritis.
de réir: Yadav, Raju
Foilsithe / Cruthaithe: (2016)

Ensuring balance in national policies on control substances: Guidelines for availability and accessibility of controlled medicines
Foilsithe / Cruthaithe: (2011)

Clinical trials: study design, endpoints and biomarkers, drug safety, and FDA and ICH guidelines
de réir: Brody, Tom
Foilsithe / Cruthaithe: (2016)

Evaluation of certain veterinary drug residues in food
Foilsithe / Cruthaithe: (2000)

WHO Expert Committee on biological standardization sixty-fourth meeting report /

Study on the Projection and Management of Health Care Professionals for the Next Ten Years
de réir: Aryal, BK, et al.
Foilsithe / Cruthaithe: (2016)

Impact of educational intervention on knowledge and practice of safety precaution of cytotoxic drugs administration among nurse.
de réir: Pande, Sarala
Foilsithe / Cruthaithe: (2011)

Status of Ayurvedic medicines available in the markets of Nepal
de réir: Adhikari, Shyam Mani
Foilsithe / Cruthaithe: (2008)

Status of Ayurvedic Medicines Available in the Markets of Nepal
de réir: Adhikari, Shyam Mani, Dr.
Foilsithe / Cruthaithe: (2012)

Evaluation of certain veterinary drug residues in food: Forty- second report of the joint FAO/WHO expert committee on food additives
Foilsithe / Cruthaithe: (1995)

Fundamentals of Clinical Trials /
de réir: Friedman, Lawrence M, et al.
Foilsithe / Cruthaithe: (2015)

Evaluation of certain veterinary drug residues in food : seventy-fifth[75th] report of the Joint FAO/WHO Expert Committee on Food Additives
Foilsithe / Cruthaithe: (2012)

The use of essential drugs : ninth report of the WHO Expert Committee (including the revised Model list of essential drugs).
Foilsithe / Cruthaithe: (2000)

Drug policy in the Americas
de réir: Smith, Peter H.
Foilsithe / Cruthaithe: (1992)

Ensuring balance in national policies on controlled substances Guidance for availability and accessibility of controlled medicines
Foilsithe / Cruthaithe: (2011)

Ensuring balance in national policies on controlled substances Guidance for availability and accessibility of controlled medicines
Foilsithe / Cruthaithe: (2011)

Iodized salt social marketing campaign (ISMAC): Baseline Study
de réir: Poudel, Krishna Prasad
Foilsithe / Cruthaithe: (2015)

Public Health Care Expenditures in Nepal: Review, Analysis and Assessment
de réir: Maskay, NM, et al.
Foilsithe / Cruthaithe: (2016)